Synalar
Synalar

21.8
A generic medicine indicated for skin conditions. Addresses redness and swelling by suppressing localized chemical responses that promote inflammation.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Fluocinolone acetonide
Reference Brand
Fluocinolone acetonide
Product Origin
Generic Alternative
Reference Manufacturer
Medicopharma
Product Form
Cream
Regulatory Classification
Prescription Only Medicine
Primary Category
Skin Care, Skin Care
Product Category
Topical Corticosteroid
Pharmacological Class
Glucocorticoid
Clinical Indications
Manufacturer Description
Developed to mitigate localized skin swelling and itching to support skin barrier restoration and alleviate irritation.
Mechanism of Action
Stimulates local lipocortin synthesis, which blocks phospholipase A2 to prevent local prostaglandin and leukotriene synthesis.
Route of Administration
Topical
Onset Time
1–3 days
Duration
12 hours
Contraindications
Untreated skin infections, Rosacea, Hypersensitivity to fluocinolone
Severe Adverse Events
Adrenal suppression — requires immediate medical attention
Common Side Effects
Local burning, Stinging, Dry skin
Uncommon Side Effects
Skin thinning, Erythema, Local pruritus
Pregnancy Safety Warnings
TGA Category C: Use if potential benefits justify risks. Breastfeeding: Do not apply to breasts.
Age Restrictions
Approved for children and adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Synalar is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to purchase Focus & Concentration Tablets - Strattera Australia